Related Experiment Video
Updated: Feb 16, 2026
09:40
Organoid-Derived Epithelial Monolayer: A Clinically Relevant In Vitro Model for Intestinal Barrier Function
Published on: July 29, 2021
7.4K
Kras in Organoids
1CSHL Cancer Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11743.
Cold Spring Harbor Perspectives in Medicine
|January 10, 2018
Summary
Organoid technology offers a superior model for studying Kras-driven pancreatic and colorectal cancers. This method allows for detailed analysis of tumor initiation and therapeutic strategies.
Area of Science:
- Oncology
- Cancer Biology
- Biotechnology
Background:
- Oncogenic Kras mutations are key drivers in pancreatic and colorectal adenocarcinomas.
- Understanding Kras tropism in these cancers is crucial for developing targeted therapies.
- Traditional 2D cultures have limitations in representing complex tumor microenvironments.
Purpose of the Study:
- To highlight the advantages of organoid technology in modeling Kras-driven cancers.
- To compare organoid models with traditional 2D and in vivo models.
- To explore the potential of organoids in studying tumor initiation and therapeutic efficacy.
Main Methods:
- Utilizing advanced organoid technology for pancreatic and colon epithelial tissues.
- Comparing organoid cultures with 2D cultures and in vivo models.
- Employing syngeneic orthotopic transplantation of organoids.
Main Results:
- Organoid technology provides a more representative culture system for non-immortalized cells.
- Organoids facilitate direct comparison of tumor and normal tissue models.
- Transplanted organoids accurately recapitulate tumor histology and gene expression.
Conclusions:
- Organoid cultures offer significant advantages for studying Kras-driven tumors.
- This technology enhances the investigation of tumor-cell interactions and dependencies.
- Organoids may extend the utility of genetically engineered mouse models in cancer research.
